Investment type
Equity / Common Stock, par value $0.0001 per share
Latest Disclosed Shares Owned
1,872,142 shares
Security Ownership %
4.9%

Novo Holdings A/S ownership in ArriVent BioPharma, Inc. Common Stock, par value $0.0001 per share

14 Aug 2025 - Novo Holdings A/S has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 1,872,142 shares of ArriVent BioPharma, Inc. Common Stock, par value $0.0001 per share. This represents 4.9% ownership of the company. In their previous filing dated 14 Feb 2025, Novo Holdings A/S had reported owning 1,750,000 shares, indicating an increase of +7%. .